Plunkett Research Online: Yuhan Corporation

YUHAN CORPORATION (000100) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Yuhan Corporation is a pharmaceuticals company that develops drugs for diabetes, viral and fungus infection, osteoporosis, arthritis, cancer and hepatitis C. Yuhan’s first fully developed drug, Revanex, an anti-ulcer agent for gastrointestinal diseases, is one of the first new drugs ever developed .....


YUHAN CORPORATION

Ticker: 000100
Exchange: Seoul
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 82-2-828-0181
Fax: 82-2-828-0050
Address: 74, Noryangjin-ro, dongjak-gu
Seoul, South Korea

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Jung Hee LeeCEO
Chris C.K. SaDir.-New Prod. Dev.
See More
Yuhan Corporation is a pharmaceuticals company that develops drugs for diabetes, viral and fungus infection, osteoporosis, arthritis, cancer and hepatitis C. Yuhan’s first fully developed drug, Revanex, an anti-ulcer agent for gastrointestinal diseases, is one of the first new drugs ever developed .....See More See More

$USD, In whole numbers 2016201520142013201220112010
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture